title: Author's reply: To PMID 25370543.
authors: J R
authors: JR
authors: Wisler
authors: A N
authors: AN
authors: Springer
authors: K
authors: K
authors: Hateley
authors: X M
authors: XM
authors: Mo
authors: D C
authors: DC
authors: Evans
authors: C H
authors: CH
authors: Cook
authors: A T
authors: AT
authors: Gerlach
authors: C V
authors: CV
authors: Murphy
authors: D S
authors: DS
authors: Eiferman
authors: S M
authors: SM
authors: Steinberg
authors: S D
authors: SD
authors: Bergese
authors: T J
authors: TJ
authors: Papadimos
authors: S P
authors: SP
authors: Stawicki
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D019338:Polypharmacy; D014947:Wounds and Injuries / Q000150:complications*
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors